What is a randomised controlled trial (RCT)?
A randomised controlled trial (RCT) assigns participants by chance to a treatment group and a control group and compares the outcomes. Chance makes the groups as similar as possible at the start. This is why the RCT is regarded as the gold standard for testing whether an intervention works.
RCT explained
Two words carry the idea:
- Controlled: there is a comparison group receiving a placebo or standard treatment instead of the active compound.
- Randomised: chance, not the researchers or participants, decides who goes into which group.
Why does it matter? Without random assignment, groups might differ systematically in age, health or expectations. You would not know whether a difference comes from the compound or from those factors.
Blinding and other quality features
In a double-blind study neither participants nor clinicians know who gets what, which limits expectation effects. Other features of good RCTs:
- Adequate sample size so that chance variation does not dominate
- Pre-specified primary outcome so a convenient result is not chosen afterwards
- Transparent handling of dropouts
- Comparable dose and preparation, often a problem in turmeric research
A special form is the crossover design: each person receives both variants one after another, with a washout in between, acting as their own control. This is common in absorption (pharmacokinetic) studies.
Where does the RCT sit in the evidence hierarchy?
Simplified ranking from more to less reliable
| Study type | Strength of evidence | Typical weakness |
|---|---|---|
| Study type Meta-analysis / systematic review of RCTs | Strength of evidence High | Typical weakness Only as good as included studies |
| Study type Randomised controlled trial | Strength of evidence High | Typical weakness Often small groups, short duration |
| Study type Observational study | Strength of evidence Moderate | Typical weakness Confounders hard to exclude |
| Study type Animal and cell studies | Strength of evidence Low for humans | Typical weakness Transferability unclear |
| Study type Anecdotes, personal experience | Strength of evidence Very low | Typical weakness No control |
Reading RCTs on turmeric and curcumin
There are many RCTs on curcumin, but with different preparations, doses and sample sizes, which often leads to mixed results. Practical questions: How many people took part? Was there a placebo? How long did it run? Which curcumin preparation was used, and is it comparable to the product you are looking at? A positive RCT with 30 people is a hint, not proof. Several RCTs together are pooled in a meta-analysis.
How to read an RCT in five steps
- Question: Which group was studied (age, condition) and does it resemble you?
- Comparison: Placebo, standard therapy or nothing? A comparison with “nothing” is weaker.
- Outcome: Was a lab value measured or a feeling such as pain? Both are legitimate but mean different things.
- Size and duration: Small, short studies give hints, not certainty.
- Funding and registration: Was the study registered in advance, and are there conflicts of interest?
This turns a headline into an assessment.
Frequently asked questions
Why is an RCT better than an observational study? Because random assignment distributes confounders evenly across groups. In observational studies differences such as lifestyle can distort the result.
Does “significant” mean “important”? No. Statistically significant only means a difference is unlikely to be due to chance. Whether you would notice it depends on the size of the effect.
What is the placebo effect? Expectation alone can noticeably change complaints, especially pain. That is why a control group is needed.
How many participants are enough? It depends on the question. For complaints such as pain, studies with clearly more participants are more informative than very small groups; there is no fixed minimum, as the required sample size depends on the question. Absorption studies need fewer because blood levels can be measured precisely. An absorption study of a γ-cyclodextrin curcumin formulation, for example, had 12 healthy adults in a double-blind crossover design; it says something about absorption, not about symptoms.
An RCT tells you about the studied group under study conditions. For an individual it is never a guarantee.
